RxDoctor Payments Data

Adrianne Bear

Family · Paducah, KYNPI 1396248795

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $498, 4.3 times the $115 reported in 2021.

$1,468in general payments, 2019–2025

Across 48 payments — averaging $30.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$161
  • Novo Nordisk$142
  • Si-bone, Inc.$129
  • AstraZeneca$128
  • AbbVie$125
  • Jazz Pharmaceuticals Inc.$115
  • plus $669 from 15 others

What the payments were for

  • Food & beverage$1,468100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,468 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$12,693
Atorvastatin Calcium58$356
Duloxetine Hcl15$260
Omeprazole19$172
Pantoprazole Sodium17$154
Lisinopril25$151
Dicyclomine Hcl13$125
Levothyroxine Sodium13$124
Losartan Potassium18$123
Azelastine Hcl11$122
Montelukast Sodium16$108
Trazodone Hcl11$97
Amlodipine Besylate30$58
Fluticasone Propionate14$57
Alendronate Sodium12$52

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$12,69315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →